David C. Benedicto - May 23, 2021 Form 3 Insider Report for Adamis Pharmaceuticals Corp (ADMP)

Role
Principal Accounting Officer
Signature
/s/David C. Benedicto
Stock symbol
ADMP
Transactions as of
May 23, 2021
Transactions value $
$0
Form type
3
Date filed
6/2/2021, 05:36 PM
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ADMP Common Stock 6.39K May 23, 2021 Direct
holding ADMP Common Stock 50.6K May 23, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADMP Employee Stock Option (right to buy) May 23, 2021 Common Stock 30K $4.10 Direct F2
holding ADMP Employee Stock Option (right to buy) May 23, 2021 Common Stock 18.8K $4.10 Direct F3
holding ADMP Employee Stock Option (right to buy) May 23, 2021 Common Stock 51K $3.15 Direct F4
holding ADMP Employee Stock Option (right to buy) May 23, 2021 Common Stock 104K $2.83 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units (RSUs) granted to the Reporting Person on January 30, 2019. Each RSU represents a contingent right to receive one share of the issuer's common stock. The RSUs vest ratably over a period of approximately three years with respect to approximately 1/12 of the total number of RSUs on each on May 17, August 17, November 17 and March 17 of each year, provided that the Reporting Person has continued to provide services to the Company during such period. The RSUs vest earlier in connection with a Change in Control of the Company (as defined in the Plan and the applicable award agreement) or upon the death or disability of the Reporting Person, and the shares covered by the RSU are issuable following vesting as provided in the Plan and award agreement. The RSUs are granted pursuant to the 2009 Equity Incentive Plan and are subject to other provisions in the applicable award agreement.
F2 The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the December 1, 2014 grant date, subject to the Reporting Person's continued service to the Issuer through such vesting date.
F3 The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the January 25, 2016 grant date, subject to the Reporting Person's continued service to the Issuer through such vesting date.
F4 The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the February 07, 2017 grant date, subject to the Reporting Person's continued service to the Issuer through such vesting date.
F5 The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the February 21, 2018 grant date, subject to the Reporting Person's continued service to the Issuer through such vesting date.